...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: google
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Still no change thus far on google:

Zenith Capital

Biotechnology company
Zenith Capital Corp. of Canada operates as a clinical stage biotechnology company. The Company develops bromodomain and extraterminal domain protein inhibitors for the treatment of cancer and other disorders with significant unmet medical need. Zenith Capital serves customers worldwide.

Zenith Capital Corp/Canada - Company Profile and News ...

www.bloomberg.com › profile › company
 
 

Description

Stock price: ZENI.P (CVE) $0.20 0.00 (0.00%)
Sep. 18, 12:20 p.m. EDT - Disclaimer
Founded: 2013
_______________________________________________________________
 
Koo

 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply